{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T05:28:58Z","timestamp":1745386138456},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T00:00:00Z","timestamp":1534204800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s00391-018-1436-2","type":"journal-article","created":{"date-parts":[[2018,8,14]],"date-time":"2018-08-14T13:37:03Z","timestamp":1534253823000},"page":"744-750","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Erkrankungen des schizophrenen Formenkreises im Alter","Diseases of the schizophrenia spectrum disorder in old age"],"prefix":"10.1007","volume":"51","author":[{"given":"Christian","family":"Jagsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Hofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,14]]},"reference":[{"issue":"Suppl 2","key":"1436_CR1","first-page":"5","volume":"65","author":"GS Alexopoulos","year":"2004","unstructured":"Alexopoulos GS, Streim JE, Carpenter D (2004) Using antipsychotic agents in older patients. J\u00a0Clin Psychiatry 65(Suppl 2):5\u201399 (discussion 100\u2013102; quiz 103\u20134)","journal-title":"J Clin Psychiatry"},{"issue":"11","key":"1436_CR2","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1097\/00005053-200211000-00002","volume":"190","author":"Y Barak","year":"2002","unstructured":"Barak Y, Aizenberg D, Mirecki I et al (2002) Very late-onset schizophrenia-like psychosis: clinical and imaging characteristics in comparison with elderly patients with schizophrenia. J Nerv Ment Dis 190(11):733\u2013736","journal-title":"J. Nerv. Ment. Dis."},{"key":"1436_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1002\/gps.2702","volume":"27","author":"S Brunelle","year":"2012","unstructured":"Brunelle S, Cole MG, Elie M (2012) Risc factors for the late-onset psychoses: a\u00a0systematic review of cohort studies. Int J Geriatr Psychiatry 27:240\u2013252","journal-title":"Int J Geriatr Psychiatry"},{"key":"1436_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4137\/JCNSD.S4125","volume":"3","author":"R Catal\u00e1n","year":"2011","unstructured":"Catal\u00e1n R, Penad\u00e9s R (2011) Risperidone long-acting injection: safety and efficacy in elderly patients with schizophrenia. Review. J\u00a0Cent Nerv Syst Dis 3:95","journal-title":"J Cent Nerv Syst Dis"},{"issue":"1","key":"1436_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/00019442-200002000-00003","volume":"8","author":"CI Cohen","year":"2000","unstructured":"Cohen CI, Cohen GD, Blank K et\u00a0al (2000) Schizophrenia and old adults. An overview: directions for research and policy. Am J Geriatr Psychiatry 8(1):19\u201328","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"1436_CR6","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/HRP.0000000000000068","volume":"23","author":"MA Colijn","year":"2015","unstructured":"Colijn MA, Nitta BH, Grossberg GT (2015) Psychosis in later life: a\u00a0review and update. Harv Rev Psychiatry 23(5):354\u2013367","journal-title":"Harv Rev Psychiatry"},{"key":"1436_CR7","volume-title":"Internationale Klassifikation psychischer St\u00f6rungen \u2013 ICD-10 KapitelV(F)","author":"H Dilling","year":"2005","unstructured":"Dilling H, Mombour W, Schmidt MH (2005) Internationale Klassifikation psychischer St\u00f6rungen \u2013 ICD-10 KapitelV(F). Huber, Bern"},{"issue":"Suppl 3","key":"1436_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.4088\/JCP.7075su1c.04","volume":"70","author":"A Fagiolini","year":"2009","unstructured":"Fagiolini A, Goracci A (2009) The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J\u00a0Clin Psychiatry 70(Suppl 3):22\u201329. \n                    https:\/\/doi.org\/10.4088\/JCP.7075su1c.04","journal-title":"J Clin Psychiatry"},{"key":"1436_CR9","volume-title":"S3-Behandlungsleitlinie Schizophrenie","author":"W Gaebel","year":"2006","unstructured":"Gaebel W, Falkai P (2006) S3-Behandlungsleitlinie Schizophrenie. Deutsche Gesellschaft f\u00fcr Psychiatrie, Psychotherapie und Nervenheilkunde (DGPPN), Berlin"},{"key":"1436_CR10","first-page":"19","volume-title":"Schizophrenia into later life: Treatment, research and policy","author":"CM Harding","year":"2003","unstructured":"Harding CM (2003) Changes in schizophrenia across time. In: Cohen CI (Hrsg) Schizophrenia into later life: Treatment, research and policy. Arlington, American Psychiatric, S\u00a019\u201341"},{"key":"1436_CR11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3109\/15622975.2012.696143","volume":"13","author":"A Hasan","year":"2012","unstructured":"Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthoj B, Gattaz WF, Thibaut F, M\u00f6ller HJ (2012) World Federation of Societies of Biological Psychiatry (WFSBP), Task Force on Treatment Guidelines for Schizophrenia. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance. World J Biol Psychiatry 13:318\u2013378.","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"1436_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1176\/appi.ajp.157.2.172","volume":"157","author":"R Howard","year":"2000","unstructured":"Howard R, Rabins PV, Seeman MV et al (2000) Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. Am J Psychiatry 157(2):172\u2013178","journal-title":"Am J Psychiatry"},{"issue":"2","key":"1436_CR13","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.psc.2011.02.008","volume":"34","author":"A Iglewicz","year":"2011","unstructured":"Iglewicz A, Meeks TW, Jeste DV (2011) New wine in old bottle: late life psychosis. Psychiatr Clin North Am 34(2):295\u2013318","journal-title":"Psychiatr Clin North Am"},{"issue":"2","key":"1436_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s40211-016-0183-0","volume":"30","author":"C Jagsch","year":"2016","unstructured":"Jagsch C, Dietmaier G, Jagsch M, Kurz M (2016) Clinical diagnosis and drug therapy of elderly patients with schizophrenia: a restrospective analysis of data in a\u00a0department of old age psychiatry. Neuropsychiatr 30(2):74\u201381. \n                    https:\/\/doi.org\/10.1007\/s40211-016-0183-0","journal-title":"Neuropsychiatr"},{"issue":"2","key":"1436_CR15","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s00391-016-1107-0","volume":"51","author":"C Jagsch","year":"2018","unstructured":"Jagsch C, Dietmaier G, Jagsch M, Roller RE (2018) Erkrankungen des schizophrenen Formenkreises bei \u00e4lteren Patienten. Analyse der Aufnahmegr\u00fcnde in einer Abteilung f\u00fcr Alterspsychiatrie. Z\u00a0Gerontol Geriatr 51(2):206\u2013212. \n                    https:\/\/doi.org\/10.1007\/s00391-016-1107-0","journal-title":"Z Gerontol Geriatr"},{"issue":"3","key":"1436_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1684\/pnv.2011.0285","volume":"9","author":"I Jalenques","year":"2011","unstructured":"Jalenques I, Rachez C, Tourtauchaux R, Cellier Y, Legrand G (2011) Old patients suffering from long-standing schizophrenia: clinical aspects. Geriatr Psychol Neuropsychiatr Vieil 9(3):345\u2013353. \n                    https:\/\/doi.org\/10.1684\/pnv.2011.0285","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"issue":"5","key":"1436_CR17","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/schbul\/sbt043","volume":"39","author":"DV Jeste","year":"2013","unstructured":"Jeste DV, Maglione JE (2013) Treating older adults with schizophrenia: challenges andopportunities. Schizophr Bull 39(5):966\u2013968","journal-title":"Schizophr. Bull."},{"issue":"6","key":"1436_CR18","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/00019442-200311000-00008","volume":"11","author":"DV Jeste","year":"2003","unstructured":"Jeste DV, Barak Y, Madhusoodanan S, Grossman F, Gharabawi G (2003) International multisite double-blind trial of the atypical antipsychotics risperidone and olanzapine in 175 elderly patients with chronic schizophrenia. Am J Geriatr Psychiatry 11(6):638\u2013647","journal-title":"Am J Geriatr Psychiatry"},{"key":"1436_CR19","first-page":"1","volume":"Einzelband(Sond","author":"S Kasper","year":"2016","unstructured":"Kasper S, Sachs G, Bach M, Erfurth A, Frey R, Fruhw\u00fcrth G, Geretsegger C, G\u00f6\u00dfler R, Hofer A, Jagsch C, Kapfhammer HP, Kienbacher C, Klier C, Lehofer M, Marksteiner J, Miller-Reiter E, Psota G, Rados C, Rainer M, Willeit M, Windhager E (2016) Schizophrenie Medikament\u00f6se Therapie Konsensus-Statement \u2013 State of the art \u00d6sterreichische Gesellschaft f\u00fcr Neuropsychopharmakologie und Biologische Psychiatrie. CliniCum Neuropsy Einzelband(Sonderausgabe): 1\u201331","journal-title":"CliniCum Neuropsy"},{"issue":"3","key":"1436_CR20","first-page":"26","volume":"60","author":"HR Khouzam","year":"2005","unstructured":"Khouzam HR, Battista MA, Emes R, Ahles S (2005) Psychoses in late life: evaluation and management of disorders seen in primary care. Geriatrics 60(3):26\u201333","journal-title":"Geriatrics"},{"issue":"1","key":"1436_CR21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/JGP.0b013e31823bc08c","volume":"20","author":"DA Loewenstein","year":"2012","unstructured":"Loewenstein DA, Czaja SJ, Bowie CR, Harvey PD (2012) Age-associated differences in cognitive performance in older patients with schizophrenia: a\u00a0comparison with healthy older adults. Am J Geriatr Psychiatry 20(1):29\u201340. \n                    https:\/\/doi.org\/10.1097\/JGP.0b013e31823bc08c","journal-title":"Am J Geriatr Psychiatry"},{"key":"1436_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/epirev\/mxn001","volume":"30","author":"J McGrath","year":"2008","unstructured":"McGrath J, Saha S, Chant D, Welham J (2008) Schizophrenia: a\u00a0concise overview of incidence, prevalence, and mortality. Epidemiol Rev 30:67\u201376","journal-title":"Epidemiol Rev"},{"issue":"12","key":"1436_CR23","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J et\u00a0al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65(12):1863\u20131872","journal-title":"Neurology"},{"issue":"1\u20133","key":"1436_CR24","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.schres.2010.09.003","volume":"126","author":"PD Meesters","year":"2011","unstructured":"Meesters PD, Comijs HC, de Haan L, Smit JH, Eikelenboom P, Beekman AT, Stek ML (2011) Symptomatic remission and associated factors in a\u00a0catchment area based population of older patients with schizophrenia. Schizophr Res 126(1\u20133):237\u2013244","journal-title":"Schizophr Res"},{"issue":"1","key":"1436_CR25","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1097\/JGP.0b013e3182011b7f","volume":"20","author":"PD Meesters","year":"2011","unstructured":"Meesters PD, de Haan L, Comijs HC, Stek ML, Smeets-Janssen MM, Weeda MR, Eikelenboom P, Smit JH, Beekman AT (2011) Schizophrenia spectrum disorders in later life: prevalence and distribution of age at onset and sex in a\u00a0dutch catchment area. Am J Geriatr Psychiatry 20(1):18\u201328. \n                    https:\/\/doi.org\/10.1097\/JGP.0b013e3182011b7f","journal-title":"Am J Geriatr Psychiatry"},{"key":"1436_CR26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1097\/JCP.0b013e3182905796","volume":"33","author":"MR Mews","year":"2013","unstructured":"Mews MR, Quante A (2013) Comparative efficacy and acceptability of existing pharmacotherapies for delusional disorder: a\u00a0retrospective case series and review of the literature. J\u00a0Clin Psychopharmacol 33:512\u2013519","journal-title":"J Clin Psychopharmacol"},{"key":"1436_CR27","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ajp.2018.03.008","volume":"33","author":"SSR Mukku","year":"2018","unstructured":"Mukku SSR, Sivakumar PT, Varghese M (2018) Clozapine use in geriatric patients\u2014challenges. Asian J Psychiatr 33:63\u201367","journal-title":"Asian J. Psychiatr."},{"issue":"12","key":"1436_CR28","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","volume":"72","author":"M Olfson","year":"2015","unstructured":"Olfson M, Gerhard T, Huang C, Crystal S, Stroup TS (2015) Premature mortality among adults with schizophrenia in the United States. JAMA Psychiatry 72(12):1172\u20131181","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"1436_CR29","doi-asserted-by":"publisher","first-page":"108","DOI":"10.24869\/psyd.2017.108","volume":"29","author":"P Piotrowski","year":"2017","unstructured":"Piotrowski P, Gondek TM, Kr\u00f3licka-Deregowska A, Misiak B, Adamowski T, Kiejna A (2017) Causes of mortality in schizophrenia: an updated review of European studies. Psychiatr Danub 29(2):108\u2013120","journal-title":"Psychiatr Danub"},{"key":"1436_CR30","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11920-996-0050-y","volume":"4","author":"JA Sable","year":"2002","unstructured":"Sable JA, Jeste JV (2002) Antipsychotic treatment for late-life schizophrenia. Curr Psychiatry Rep 4:299\u2013306","journal-title":"Curr Psychiatry Rep"},{"key":"1436_CR31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2165\/11595830-000000000-00000","volume":"28","author":"T Suzuki","year":"2011","unstructured":"Suzuki T, Remington G, Uchida H, Rajji TK, Graff-Guerrero A, Mamo DC (2011) Management of schizophrenia in late life with antipsychotic medications: a\u00a0qualitative review. Drugs Aging 28:961\u2013980","journal-title":"Drugs Aging"},{"issue":"5","key":"1436_CR32","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1600-0447.2010.01552.x","volume":"122","author":"IV Vahia","year":"2010","unstructured":"Vahia IV, Palmer BW, Depp C et al (2010) Late-onset schizophrenia: a subtype of schizophrenia? Acta Psychiatr Scand 122(5):414\u2013426","journal-title":"Acta Psychiatr Scand"},{"key":"1436_CR33","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.neubiorev.2017.08.024","volume":"83","author":"L Assche Van","year":"2017","unstructured":"Van Assche L, Morrens M, Luyten P, Van de Ven L, Vandenbulcke M (2017) The neuropsychology and neurobiology of late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: a\u00a0critical review. Neurosci Biobehav Rev 83:604\u2013621","journal-title":"Neurosci Biobehav Rev"},{"issue":"7321","key":"1436_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nature09563","volume":"468","author":"J Os Van","year":"2010","unstructured":"Van Os J, Kenis G, Rutten BP (2010) The environment and schizophrenia. Nature 468(7321):203\u2013212. \n                    https:\/\/doi.org\/10.1038\/nature09563","journal-title":"Nature"},{"issue":"19","key":"1436_CR35","doi-asserted-by":"publisher","first-page":"15101","DOI":"10.18632\/oncotarget.24120","volume":"9","author":"C Yang","year":"2018","unstructured":"Yang C, Hao Z, Tian J, Zhang W, Li W, Zhang L, Song F (2018) Does antipsychotic drug use increase the risk of long term mortality. A systematic review and meta-analysis of observational studies. Oncotarget 9(19):15101\u201315110","journal-title":"Oncotarget"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00391-018-1436-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-018-1436-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-018-1436-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T06:23:11Z","timestamp":1567146191000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00391-018-1436-2"}},"subtitle":["Diagnostische und therapeutische Herausforderungen","Diagnostic and therapeutic challenges"],"short-title":[],"issued":{"date-parts":[[2018,8,14]]},"references-count":35,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1436"],"URL":"https:\/\/doi.org\/10.1007\/s00391-018-1436-2","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"type":"print","value":"0948-6704"},{"type":"electronic","value":"1435-1269"}],"subject":[],"published":{"date-parts":[[2018,8,14]]},"assertion":[{"value":"7 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Jagsch hat von den Firmen Janssen und Pfizer Honorare f\u00fcr Vortr\u00e4ge sowie Kongress- und Reisekostenunterst\u00fctzung erhalten. A.\u00a0Hofer hat von den Firmen Janssen und Lundbeck Honorare f\u00fcr Vortr\u00e4ge sowie Kongress- und Reisekostenunterst\u00fctzung erhalten.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}